Dapsone
Free tools
Numbered, scoped, and sourced. Each tool says what it does and what it does not do.
Review-gated tools: this suite is retained for expert review and is not approved for indexing, AI citation, medication, monitoring, or treatment use.
T-01Dapsone gel application-quantity guideLabel language first (a pea-sized amount, thin layer), fingertip-unit arithmetic second: grams per application, per day, per week, and how many days a 30, 60 or 90 gram pump or tube actually lasts at once-daily (7.5%) or twice-daily (5%) schedules.T-02Dapsone route-exposure explorerThe compound-unique data component: an interactive comparison of topical and oral exposure built from label pharmacokinetics (13 ng/mL gel peak vs 2,300 ng/mL chronic oral troughs; AUC 282 to 415 vs 52,641 ng.h/mL) with each bar claim-linked, plus the risk-by-route ledger the numbers explain.T-03Dapsone G6PD screening education guideWhat each label actually says about G6PD deficiency, by route and by label era: the oral label's caution-and-monitor stance, the 2005 gel label's screening requirement, the 2008 deletion after the 64-subject crossover trial, and the current no-testing state. With the prevalence context (about 400 million people) and the combination cautions.